How will we beat back the COVID-19 pandemic and respond better to future pandemics?

I talk with three leading scientists about these critical issues on the 12th and final episode of the series, “COVID-19: The Texas A&M System Responds.”

Dr. James Samuel, a regents’ professor at the Texas A&M College of Medicine, tells me about his lab’s important work with the international biotech company iBio Inc. They are testing two vaccine candidates in mice that could be mass produced quickly using modified tobacco plants.

I also visit with Dr. Gerald Parker, director of the Texas A&M Pandemic and Biosecurity Policy Program, and Dr. Peter Hotez, a Hagler Institute Scholar and vaccine researcher at Baylor College of Medicine in Houston. We discuss many of the latest COVID-19 developments and how policymakers can learn from this outbreak to respond better next time.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.